(+)-epicatechin-3-O-gallate increases activity ISO RGD:736474 6480464 epicatechin gallate results in increased activity of G6PD protein CTD PMID:26187476 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of G6PD mRNA] CTD PMID:31150632 (E)-cinnamyl alcohol increases expression ISO RGD:736474 6480464 cinnamyl alcohol results in increased expression of G6PD mRNA CTD PMID:20566472 (R)-noradrenaline increases activity EXP 6480464 Norepinephrine results in increased activity of G6PD mRNA, Norepinephrine results in increased activity of G6PD protein CTD PMID:1378361 , PMID:7605896 (R)-noradrenaline multiple interactions EXP 6480464 Metoprolol inhibits the reaction [Norepinephrine results in increased activity of G6PD protein], Prazosin inhibits the reaction [Norepinephrine results in increased activity of G6PD protein] CTD PMID:1378361 (R)-noradrenaline increases expression EXP 6480464 Norepinephrine results in increased expression of G6PD mRNA CTD PMID:7605896 (S)-naringenin multiple interactions EXP 6480464 [naringenin co-treated with lead acetate] results in decreased activity of G6PD protein, naringenin inhibits the reaction [Cadmium Chloride results in decreased expression of G6PD protein] CTD PMID:19063931 , PMID:25228019 (S)-naringenin decreases activity ISO RGD:736474 6480464 naringenin results in decreased activity of G6PD protein CTD PMID:25130191 (S)-naringenin decreases activity EXP 6480464 naringenin results in decreased activity of G6PD protein CTD PMID:25228019 (S)-nicotine decreases activity EXP 6480464 Nicotine results in decreased activity of G6PD protein CTD PMID:20498001 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:736474 6480464 Dinitrochlorobenzene results in increased expression of G6PD mRNA CTD PMID:20566472 1-methylphenanthrene multiple interactions ISO RGD:736474 6480464 [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of G6PD mRNA CTD PMID:17690111 17alpha-ethynylestradiol multiple interactions ISO RGD:10608 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of G6PDX mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of G6PDX mRNA CTD PMID:16174780 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of G6PDX mRNA CTD PMID:17108234 17alpha-ethynylestradiol increases expression ISO RGD:10608 6480464 Ethinyl Estradiol results in increased expression of G6PDX mRNA CTD PMID:16174780 , PMID:17942748 17beta-estradiol multiple interactions ISO RGD:10608 6480464 [bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of G6PDX mRNA more ... CTD PMID:10433208 , PMID:27312807 17beta-estradiol multiple interactions ISO RGD:736474 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of G6PD mRNA CTD PMID:30165855 17beta-estradiol increases expression ISO RGD:10608 6480464 Estradiol results in increased expression of G6PDX mRNA CTD PMID:10433208 , PMID:19484750 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one decreases expression ISO RGD:736474 6480464 Metribolone results in decreased expression of G6PD protein CTD PMID:17152098 1H-pyrazole multiple interactions ISO RGD:10608 6480464 G6PDX affects the reaction [pyrazole results in increased expression of and results in increased activity of CYP2A5 protein] more ... CTD PMID:18068688 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:10608 6480464 2 more ... CTD PMID:29935226 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10608 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of G6PDX mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to G6PDX promoter] CTD PMID:17942748 , PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10608 6480464 Tetrachlorodibenzodioxin affects the expression of G6PDX mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10608 6480464 Tetrachlorodibenzodioxin results in decreased expression of G6PD protein, Tetrachlorodibenzodioxin results in decreased expression of G6PDX mRNA CTD PMID:21354282 , PMID:29935226 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of G6PD mRNA, Tetrachlorodibenzodioxin results in increased expression of G6PDX mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of G6PD mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10608 6480464 Tetrachlorodibenzodioxin results in increased expression of G6PDX mRNA CTD PMID:16960034 2,4-dinitrotoluene decreases expression ISO RGD:10608 6480464 2, 4-dinitrotoluene results in decreased expression of G6PDX mRNA CTD PMID:24893713 2,5-dihydroxybenzoic acid decreases activity ISO RGD:736474 6480464 2, 5-dihydroxybenzoic acid results in decreased activity of G6PD protein mutant form CTD PMID:5432368 2,5-dihydroxybenzoic acid multiple interactions ISO RGD:10608 6480464 2, 5-dihydroxybenzoic acid inhibits the reaction [Benzoyl Peroxide results in decreased activity of G6PD protein] CTD PMID:15454305 2-(4-hydroxyphenyl)ethanol multiple interactions EXP 6480464 4-hydroxyphenylethanol inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] CTD PMID:25641191 2-hydroxypropanoic acid increases expression ISO RGD:736474 6480464 Lactic Acid results in increased expression of G6PD mRNA CTD PMID:20566472 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 , PMID:20959002 3,4-dihydroxybenzaldehyde multiple interactions ISO RGD:736474 6480464 protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of G6PD protein], protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] CTD PMID:29665407 , PMID:29732668 3,4-dihydroxybenzoic acid increases activity EXP 6480464 protocatechuic acid results in increased activity of G6PD protein CTD PMID:29842870 3-phenylprop-2-enal increases expression ISO RGD:736474 6480464 cinnamic aldehyde results in increased expression of G6PD mRNA CTD PMID:19524605 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of G6PDX mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:736474 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of G6PD mRNA CTD PMID:31121516 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of G6PDX mRNA CTD PMID:21346803 4-chlorobiphenyl increases expression ISO RGD:736474 6480464 4-chlorobiphenyl metabolite results in increased expression of G6PD mRNA CTD PMID:25417049 4-hydroxynon-2-enal increases expression ISO RGD:10608 6480464 4-hydroxy-2-nonenal results in increased expression of G6PDX mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:736474 6480464 Fenretinide results in increased expression of G6PD protein CTD PMID:25246272 5-formyltetrahydrofolic acid multiple interactions EXP 6480464 Leucovorin inhibits the reaction [Methotrexate results in decreased activity of G6PD protein] CTD PMID:21213337 5-methylphenazinium methyl sulfate increases activity ISO RGD:736474 6480464 Methylphenazonium Methosulfate results in increased activity of G6PD protein CTD PMID:1901343 9-cis-retinoic acid increases expression ISO RGD:736474 6480464 Alitretinoin results in increased expression of G6PD mRNA CTD PMID:15982314 acetaldehyde increases activity EXP 6480464 Acetaldehyde results in increased activity of G6PD protein CTD PMID:8123704 acetaldehyde increases expression EXP 6480464 Acetaldehyde results in increased expression of G6PD mRNA CTD PMID:8123704 acetamide increases expression EXP 6480464 acetamide results in increased expression of G6PD mRNA CTD PMID:31881176 acetylsalicylic acid decreases response to substance ISO RGD:736474 6480464 G6PD results in decreased susceptibility to Aspirin CTD PMID:5432368 acetylsalicylic acid decreases activity ISO RGD:736474 6480464 Aspirin results in decreased activity of G6PD protein mutant form CTD PMID:5432368 actinomycin D multiple interactions EXP 6480464 Dactinomycin inhibits the reaction [Isoproterenol results in increased activity of G6PD protein] CTD PMID:1978808 aflatoxin B1 increases methylation ISO RGD:736474 6480464 Aflatoxin B1 results in increased methylation of G6PD gene CTD PMID:27153756 albuterol increases activity EXP 6480464 Albuterol results in increased activity of G6PD protein CTD PMID:1978808 all-trans-4-oxoretinoic acid increases expression ISO RGD:736474 6480464 4-oxoretinoic acid results in increased expression of G6PD mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression ISO RGD:736474 6480464 Tretinoin metabolite results in increased expression of G6PD mRNA, Tretinoin results in increased expression of G6PD mRNA CTD PMID:15982314 alpha-hexylcinnamaldehyde increases expression ISO RGD:736474 6480464 hexyl cinnamic aldehyde results in increased expression of G6PD mRNA CTD PMID:20566472 aluminium atom increases activity ISO RGD:736474 6480464 Aluminum results in increased activity of G6PD protein CTD PMID:16979867 aluminium atom increases activity EXP 6480464 Aluminum results in increased activity of G6PD protein CTD PMID:16572710 aluminium phosphide decreases activity EXP 6480464 aluminum phosphide results in decreased activity of G6PD protein CTD PMID:20929055 aluminium(0) increases activity ISO RGD:736474 6480464 Aluminum results in increased activity of G6PD protein CTD PMID:16979867 aluminium(0) increases activity EXP 6480464 Aluminum results in increased activity of G6PD protein CTD PMID:16572710 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of G6PDX mRNA CTD PMID:19224547 amiodarone increases expression ISO RGD:736474 6480464 Amiodarone results in increased expression of G6PD mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of G6PD mRNA CTD PMID:16483693 amosite asbestos decreases activity ISO RGD:736474 6480464 Asbestos, Amosite results in decreased activity of G6PD protein CTD PMID:14613721 , PMID:18370412 amosite asbestos multiple interactions ISO RGD:736474 6480464 Glutathione inhibits the reaction [Asbestos, Amosite results in decreased activity of G6PD protein] CTD PMID:14613721 androsterone decreases activity EXP 6480464 Androsterone results in decreased activity of G6PD protein CTD PMID:7752092 arjunolic acid multiple interactions EXP 6480464 arjunolic acid inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] CTD PMID:19133311 , PMID:19682444 Aroclor 1254 increases activity EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased activity of G6PD protein CTD PMID:3099627 , PMID:4005852 arsane multiple interactions EXP 6480464 silybin inhibits the reaction [Arsenic results in decreased activity of G6PD protein] CTD PMID:22229868 arsane decreases activity EXP 6480464 Arsenic results in decreased activity of G6PD protein CTD PMID:21864513 , PMID:22229868 arsenic atom decreases activity EXP 6480464 Arsenic results in decreased activity of G6PD protein CTD PMID:21864513 , PMID:22229868 arsenic atom multiple interactions EXP 6480464 silybin inhibits the reaction [Arsenic results in decreased activity of G6PD protein] CTD PMID:22229868 arsenous acid decreases expression ISO RGD:736474 6480464 Arsenic Trioxide results in decreased expression of G6PD protein CTD PMID:25419056 arsenous acid multiple interactions ISO RGD:736474 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to G6PD protein] CTD PMID:26598702 arsenous acid decreases response to substance ISO RGD:736474 6480464 G6PD protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 astaxanthin increases activity EXP 6480464 astaxanthine results in increased activity of G6PD protein CTD PMID:28665548 astaxanthin multiple interactions EXP 6480464 [Cadmium co-treated with astaxanthine] results in decreased activity of G6PD protein CTD PMID:29975440 atenolol multiple interactions EXP 6480464 Atenolol inhibits the reaction [Dopamine results in increased activity of G6PD protein], Atenolol inhibits the reaction [Isoproterenol results in increased activity of G6PD protein] CTD PMID:1978808 Bandrowski's base increases expression ISO RGD:736474 6480464 Bandrowski's base results in increased expression of G6PD mRNA CTD PMID:20566472 benzene affects expression EXP 6480464 Benzene affects the expression of G6PDX mRNA CTD PMID:15878777 benzo[a]pyrene multiple interactions ISO RGD:10608 6480464 [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of G6PDX mRNA], AHR protein affects the reaction [Benzo(a)pyrene affects the expression of G6PDX mRNA] CTD PMID:14625279 , PMID:22228805 benzo[a]pyrene increases expression ISO RGD:10608 6480464 Benzo(a)pyrene results in increased expression of G6PDX mRNA CTD PMID:14625279 more ... benzo[a]pyrene multiple interactions ISO RGD:736474 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 , PMID:24464499 benzo[a]pyrene decreases expression ISO RGD:10608 6480464 Benzo(a)pyrene results in decreased expression of G6PDX mRNA CTD PMID:22228805 benzo[b]fluoranthene multiple interactions ISO RGD:736474 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of G6PD mRNA CTD PMID:17690111 Benzo[k]fluoranthene decreases expression ISO RGD:10608 6480464 benzo(k)fluoranthene results in decreased expression of G6PDX mRNA CTD PMID:26377693 benzoic acid increases expression ISO RGD:736474 6480464 Benzoic Acid results in increased expression of G6PD mRNA CTD PMID:20566472 Benzoyl peroxide decreases activity ISO RGD:10608 6480464 Benzoyl Peroxide results in decreased activity of G6PD protein CTD PMID:12804013 more ... Benzoyl peroxide multiple interactions ISO RGD:10608 6480464 2 more ... CTD PMID:12804013 more ... beta-hexachlorocyclohexane increases activity EXP 6480464 beta-hexachlorocyclohexane results in increased activity of G6PD protein CTD PMID:2461408 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of G6PD protein CTD PMID:28903497 bezafibrate multiple interactions EXP 6480464 Bezafibrate inhibits the reaction [etomoxir results in increased activity of G6PD protein] CTD PMID:3421940 bis(2-chloroethyl) sulfide increases activity ISO RGD:10608 6480464 Mustard Gas analog results in increased activity of G6PD protein CTD PMID:15147793 bis(2-ethylhexyl) phthalate decreases activity ISO RGD:10608 6480464 Diethylhexyl Phthalate results in decreased activity of G6PD protein CTD PMID:31486570 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of G6PD mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:736474 6480464 bisphenol A results in increased expression of G6PD mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:10608 6480464 [bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of G6PDX mRNA CTD PMID:27312807 bisphenol A affects methylation ISO RGD:10608 6480464 bisphenol A affects the methylation of G6PDX promoter CTD PMID:27334623 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of G6PD protein CTD PMID:22649256 bortezomib decreases expression ISO RGD:736474 6480464 Bortezomib results in decreased expression of G6PD mRNA CTD PMID:20977926 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of G6PDX mRNA CTD PMID:12628495 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of G6PD mRNA CTD PMID:24136188 cadmium atom multiple interactions EXP 6480464 [Cadmium co-treated with astaxanthine] results in decreased activity of G6PD protein more ... CTD PMID:17125799 more ... cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of G6PD, Cadmium results in decreased expression of G6PD protein CTD PMID:17125799 , PMID:19615871 cadmium atom decreases activity EXP 6480464 Cadmium results in decreased activity of G6PD protein CTD PMID:17698948 , PMID:29975440 cadmium dichloride increases expression ISO RGD:10608 6480464 Cadmium Chloride results in increased expression of G6PDX mRNA CTD PMID:20883709 cadmium dichloride increases expression ISO RGD:736474 6480464 Cadmium Chloride results in increased expression of G6PD mRNA CTD PMID:26525392 cadmium dichloride decreases activity EXP 6480464 Cadmium Chloride results in decreased activity of G6PD protein CTD PMID:15454312 more ... cadmium dichloride multiple interactions ISO RGD:10608 6480464 Ascorbic Acid inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein], Taurine inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein] CTD PMID:18414974 more ... cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of G6PD mRNA CTD PMID:12717738 , PMID:15252869 cadmium dichloride increases activity EXP 6480464 Cadmium Chloride results in increased activity of G6PD protein CTD PMID:12717738 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of G6PD protein CTD PMID:19063931 cadmium dichloride multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cadmium Chloride results in increased expression of G6PD mRNA] more ... CTD PMID:12717738 more ... cadmium dichloride decreases activity ISO RGD:10608 6480464 Cadmium Chloride results in decreased activity of G6PD protein CTD PMID:18414974 more ... cadmium nitrate decreases activity EXP 6480464 cadmium nitrate results in decreased activity of G6PD protein CTD PMID:28557068 calcitriol increases activity ISO RGD:736474 6480464 Calcitriol results in increased activity of G6PD protein CTD PMID:8910257 calcitriol increases expression ISO RGD:736474 6480464 Calcitriol results in increased expression of G6PD mRNA CTD PMID:12040012 more ... calcitriol multiple interactions ISO RGD:736474 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of G6PD mRNA CTD PMID:21592394 carbaryl increases activity EXP 6480464 Carbaryl results in increased activity of G6PD protein CTD PMID:27214522 carbaryl multiple interactions EXP 6480464 [Malathion co-treated with Carbaryl] results in increased activity of G6PD protein, Plant Extracts inhibits the reaction [[Malathion co-treated with Carbaryl] results in increased activity of G6PD protein] CTD PMID:27214522 carbon nanotube affects expression ISO RGD:10608 6480464 Nanotubes, Carbon affects the expression of G6PDX protein CTD PMID:21135415 carbon nanotube increases expression ISO RGD:10608 6480464 Nanotubes, Carbon analog results in increased expression of G6PDX mRNA, Nanotubes, Carbon results in increased expression of G6PDX mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:10608 6480464 Nanotubes, Carbon analog results in decreased expression of G6PDX mRNA, Nanotubes, Carbon results in decreased expression of G6PDX mRNA CTD PMID:25620056 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of G6PD mRNA CTD PMID:18500788 chelerythrine decreases activity EXP 6480464 chelerythrine results in decreased activity of G6PD protein CTD PMID:19429815 chlorite decreases activity ISO RGD:736474 6480464 chlorite results in decreased activity of G6PD protein CTD PMID:27478981 chloroprene increases expression ISO RGD:10608 6480464 Chloroprene results in increased expression of G6PDX mRNA CTD PMID:23125180 chlorpromazine decreases expression ISO RGD:736474 6480464 Chlorpromazine analog results in decreased expression of G6PD mRNA CTD PMID:15924885 cinnamyl alcohol increases expression ISO RGD:736474 6480464 cinnamyl alcohol results in increased expression of G6PD mRNA CTD PMID:20566472 ciprofloxacin increases response to substance ISO RGD:736474 6480464 G6PD protein mutant form results in increased susceptibility to Ciprofloxacin CTD PMID:20127091 cis-caffeic acid decreases activity ISO RGD:736474 6480464 caffeic acid results in decreased activity of G6PD protein CTD PMID:25130191 cisplatin increases expression ISO RGD:10608 6480464 Cisplatin results in increased expression of G6PD mRNA CTD PMID:21151649 cisplatin multiple interactions ISO RGD:736474 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of G6PD mRNA CTD PMID:27392435 citronellol multiple interactions EXP 6480464 citronellol inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] CTD PMID:26944432 cobalt dichloride decreases expression ISO RGD:736474 6480464 cobaltous chloride results in decreased expression of G6PD mRNA CTD PMID:19376846 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of G6PD mRNA CTD PMID:15225644 cobalt dichloride increases activity EXP 6480464 cobaltous chloride results in increased activity of G6PD protein CTD PMID:15225644 cocaine increases expression EXP 6480464 Cocaine results in increased expression of G6PD protein CTD PMID:25100957 copper atom multiple interactions ISO RGD:736474 6480464 [NSC 689534 binds to Copper] which results in decreased expression of G6PD mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:736474 6480464 [NSC 689534 binds to Copper] which results in decreased expression of G6PD mRNA CTD PMID:20971185 crocidolite asbestos multiple interactions ISO RGD:736474 6480464 Asbestos, Crocidolite binds to and results in decreased activity of G6PD protein CTD PMID:11978496 crocidolite asbestos decreases activity ISO RGD:736474 6480464 Asbestos, Crocidolite results in decreased activity of G6PD protein CTD PMID:18370412 cumene hydroperoxide increases activity EXP 6480464 cumene hydroperoxide results in increased activity of G6PD protein CTD PMID:16928893 curcumin increases expression EXP 6480464 Curcumin results in increased expression of G6PD mRNA, Curcumin results in increased expression of G6PDX mRNA CTD PMID:18299980 cycloartenol multiple interactions ISO RGD:10608 6480464 cycloartenol inhibits the reaction [Benzoyl Peroxide results in decreased activity of G6PD protein] CTD PMID:12804013 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Isoproterenol results in increased activity of G6PD protein] CTD PMID:1978808 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of G6PDX mRNA CTD PMID:19224547 cyclosporin A decreases expression ISO RGD:736474 6480464 Cyclosporine results in decreased expression of G6PD mRNA CTD PMID:27989131 cyclosporin A increases expression ISO RGD:736474 6480464 Cyclosporine results in increased expression of G6PD mRNA CTD PMID:25562108 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with propetamphos] results in decreased activity of G6PD protein CTD PMID:25926273 cypermethrin decreases activity EXP 6480464 cypermethrin results in decreased activity of G6PD protein CTD PMID:25926273 dapsone increases response to substance ISO RGD:736474 6480464 G6PD protein mutant form results in increased susceptibility to Dapsone CTD PMID:7752092 DDT increases activity EXP 6480464 DDT results in increased activity of G6PD protein CTD PMID:12667599 DDT multiple interactions EXP 6480464 Inositol inhibits the reaction [DDT results in increased activity of G6PD protein] CTD PMID:12667599 dehydroepiandrosterone multiple interactions ISO RGD:10608 6480464 Dehydroepiandrosterone inhibits the reaction [ascorbate-2-phosphate results in increased activity of G6PD protein] CTD PMID:19746226 dexamethasone decreases activity EXP 6480464 Dexamethasone results in decreased activity of G6PD protein CTD PMID:15895680 Diallyl sulfide multiple interactions EXP 6480464 allyl sulfide inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein] CTD PMID:18972399 diarsenic trioxide decreases response to substance ISO RGD:736474 6480464 G6PD protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 diarsenic trioxide multiple interactions ISO RGD:736474 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to G6PD protein] CTD PMID:26598702 diarsenic trioxide decreases expression ISO RGD:736474 6480464 Arsenic Trioxide results in decreased expression of G6PD protein CTD PMID:25419056 diazinon affects expression EXP 6480464 Diazinon affects the expression of G6PD mRNA CTD PMID:22546817 dibenz[a,h]anthracene multiple interactions ISO RGD:736474 6480464 [Benzo(a)pyrene co-treated with 1 more ... CTD PMID:17690111 dibenzo[a,l]pyrene multiple interactions ISO RGD:736474 6480464 [Benzo(a)pyrene co-treated with dibenzo(a, l)pyrene] affects the expression of G6PD mRNA CTD PMID:17690111 dichloroacetic acid increases expression ISO RGD:10608 6480464 Dichloroacetic Acid results in increased expression of G6PDX mRNA CTD PMID:28962523 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of G6PD mRNA CTD PMID:22546817 diethyl maleate increases activity EXP 6480464 diethyl maleate results in increased activity of G6PD protein CTD PMID:3099627 digoxin decreases activity EXP 6480464 Digoxin results in decreased activity of G6PD protein CTD PMID:26820767 dihydroartemisinin affects binding ISO RGD:736474 6480464 dihydroartemisinin analog binds to G6PD protein CTD PMID:26340163 dimethoate increases activity EXP 6480464 Dimethoate results in increased activity of G6PDX protein CTD PMID:16112789 dioxygen multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of G6PD mRNA] more ... CTD PMID:15225644 dioxygen increases activity EXP 6480464 Oxygen deficiency results in increased activity of G6PD protein CTD PMID:15225644 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of G6PD mRNA CTD PMID:15225644 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:736474 6480464 Antimony Potassium Tartrate results in increased expression of G6PD mRNA, Antimony Potassium Tartrate results in increased expression of G6PD protein CTD PMID:28713220 diquat increases expression EXP 6480464 Diquat results in increased expression of G6PD mRNA, Diquat results in increased expression of G6PD protein CTD PMID:8934631 diquat increases activity ISO RGD:736474 6480464 Diquat results in increased activity of G6PD protein CTD PMID:28108222 diquat increases activity EXP 6480464 Diquat results in increased activity of G6PD protein CTD PMID:8934631 disulfiram increases expression ISO RGD:736474 6480464 Disulfiram results in increased expression of G6PD mRNA CTD PMID:20566472 diuron increases expression EXP 6480464 Diuron results in increased expression of G6PD mRNA CTD PMID:21551480 dobutamine increases activity EXP 6480464 Dobutamine results in increased activity of G6PD protein CTD PMID:1978808 dopamine increases activity EXP 6480464 Dopamine results in increased activity of G6PD protein CTD PMID:1978808 dopamine decreases activity EXP 6480464 Dopamine results in decreased activity of G6PD protein CTD PMID:26820767 dopamine multiple interactions EXP 6480464 Atenolol inhibits the reaction [Dopamine results in increased activity of G6PD protein] CTD PMID:1978808 dorsomorphin multiple interactions ISO RGD:736474 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of G6PD mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:736474 6480464 Doxorubicin results in increased expression of G6PD mRNA CTD PMID:16404146 doxorubicin affects expression ISO RGD:736474 6480464 Doxorubicin affects the expression of G6PD mRNA CTD PMID:29803840 doxorubicin affects expression EXP 6480464 Doxorubicin affects the expression of G6PD protein CTD PMID:15909818 ellagic acid decreases activity ISO RGD:736474 6480464 Ellagic Acid results in decreased activity of G6PD protein CTD PMID:25130191 endosulfan increases activity EXP 6480464 Endosulfan results in increased activity of G6PD protein, Endosulfan results in increased activity of G6PDX protein CTD PMID:2272657 more ... enzyme inhibitor multiple interactions ISO RGD:736474 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of G6PD protein CTD PMID:23301498 eugenol increases expression ISO RGD:736474 6480464 Eugenol results in increased expression of G6PD mRNA CTD PMID:20566472 fenoterol increases activity EXP 6480464 Fenoterol results in increased activity of G6PD protein CTD PMID:1978808 fenvalerate decreases activity EXP 6480464 fenvalerate results in decreased activity of G6PDX protein CTD PMID:12507254 ferulic acid decreases activity ISO RGD:736474 6480464 ferulic acid results in decreased activity of G6PD protein CTD PMID:25130191 fluoranthene multiple interactions ISO RGD:736474 6480464 [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of G6PD mRNA CTD PMID:17690111 flutamide increases expression EXP 6480464 Flutamide results in increased expression of G6PD mRNA, Flutamide results in increased expression of G6PDX mRNA CTD PMID:19299419 more ... flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of G6PD mRNA CTD PMID:24793618 fructose increases activity EXP 6480464 Fructose results in increased activity of G6PD protein CTD PMID:18346472 fructose multiple interactions EXP 6480464 Glutamine inhibits the reaction [Fructose results in decreased expression of G6PD protein] CTD PMID:31233715 fructose decreases expression EXP 6480464 Fructose results in decreased expression of G6PD protein CTD PMID:31233715 fulvestrant multiple interactions ISO RGD:10608 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of G6PDX mRNA] CTD PMID:10433208 furan increases expression EXP 6480464 furan results in increased expression of G6PD mRNA CTD PMID:25539665 , PMID:26194646 furosemide decreases activity EXP 6480464 Furosemide results in decreased activity of G6PD protein CTD PMID:26820767 Gallopamil multiple interactions EXP 6480464 Gallopamil inhibits the reaction [Isoproterenol results in increased activity of G6PD protein] CTD PMID:1978808 gamma-hexachlorocyclohexane affects activity EXP 6480464 Hexachlorocyclohexane affects the activity of G6PD protein CTD PMID:7535533 , PMID:8519523 gamma-hexachlorocyclohexane increases activity EXP 6480464 Hexachlorocyclohexane results in increased activity of G6PD protein CTD PMID:2461408 genistein 7-O-beta-D-glucoside increases expression ISO RGD:736474 6480464 genistin analog results in increased expression of G6PD mRNA CTD PMID:16719502 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of G6PD protein CTD PMID:22061828 geraniol multiple interactions ISO RGD:10608 6480464 geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of G6PD protein] CTD PMID:23399806 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] CTD PMID:28330423 glafenine increases expression EXP 6480464 Glafenine results in increased expression of G6PD mRNA CTD PMID:24136188 gliclazide multiple interactions EXP 6480464 Gliclazide inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] CTD PMID:28330423 glutaraldehyde decreases activity ISO RGD:736474 6480464 Glutaral results in decreased activity of G6PD protein CTD PMID:19490936 glutathione multiple interactions ISO RGD:736474 6480464 Glutathione inhibits the reaction [Asbestos, Amosite results in decreased activity of G6PD protein] CTD PMID:14613721 glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [Oxygen deficiency results in increased expression of G6PD mRNA] CTD PMID:15225644 glutathione multiple interactions ISO RGD:10608 6480464 Glutathione inhibits the reaction [Quartz results in decreased activity of G6PDX protein] CTD PMID:18370412 glyburide multiple interactions EXP 6480464 Glyburide inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] CTD PMID:25641191 glyoxylic acid decreases activity EXP 6480464 glyoxylic acid results in decreased activity of G6PD protein CTD PMID:15144222 glyphosate decreases activity EXP 6480464 glyphosate results in decreased activity of G6PD protein CTD PMID:24636977 , PMID:28627408 glyphosate increases activity EXP 6480464 glyphosate results in increased activity of G6PD protein CTD PMID:23820267 herbicide decreases activity EXP 6480464 Herbicides results in decreased activity of G6PD protein CTD PMID:24636977 hesperetin multiple interactions EXP 6480464 hesperetin inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein] CTD PMID:21134734 hesperidin decreases activity ISO RGD:736474 6480464 Hesperidin results in decreased activity of G6PD protein CTD PMID:25130191 hesperidin multiple interactions ISO RGD:10608 6480464 Hesperidin affects the reaction [LEPR protein affects the activity of G6PD protein] CTD PMID:16427799 Hexachloro-1,3-butadiene decreases expression EXP 6480464 hexachlorobutadiene results in decreased expression of G6PDX mRNA CTD PMID:21905055 Hexachloro-1,3-butadiene increases expression EXP 6480464 hexachlorobutadiene results in increased expression of G6PDX mRNA CTD PMID:21905055 hexane increases expression ISO RGD:736474 6480464 n-hexane results in increased expression of G6PD mRNA CTD PMID:20566472 hydrogen peroxide increases activity ISO RGD:736474 6480464 Hydrogen Peroxide results in increased activity of G6PD protein CTD PMID:15336504 hydrogen peroxide increases activity ISO RGD:10608 6480464 Hydrogen Peroxide results in increased activity of G6PD protein CTD PMID:15336504 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of G6PD mRNA CTD PMID:18299717 inositol multiple interactions EXP 6480464 [Phytic Acid co-treated with Inositol] inhibits the reaction [Streptozocin results in decreased activity of G6PD protein], Inositol inhibits the reaction [DDT results in increased activity of G6PD protein] CTD PMID:12667599 , PMID:28757134 iron trichloride decreases expression EXP 6480464 ferric chloride results in decreased expression of G6PD mRNA, ferric chloride results in decreased expression of G6PD protein CTD PMID:24599681 , PMID:30506659 iron trichloride decreases activity EXP 6480464 ferric chloride results in decreased activity of G6PD protein CTD PMID:24599681 iron(III) nitrilotriacetate decreases activity EXP 6480464 ferric nitrilotriacetate results in decreased activity of G6PD protein CTD PMID:9667754 isoeugenol increases expression ISO RGD:736474 6480464 isoeugenol results in increased expression of G6PD mRNA CTD PMID:20566472 isoflavones increases expression ISO RGD:736474 6480464 Isoflavones results in increased expression of G6PD mRNA CTD PMID:17374662 isoprenaline multiple interactions EXP 6480464 Atenolol inhibits the reaction [Isoproterenol results in increased activity of G6PD protein] more ... CTD PMID:1978808 isoprenaline increases activity EXP 6480464 Isoproterenol results in increased activity of G6PD protein CTD PMID:1978808 isosorbide dinitrate decreases response to substance ISO RGD:736474 6480464 G6PD protein results in decreased susceptibility to Isosorbide Dinitrate CTD PMID:6401899 isotretinoin decreases expression ISO RGD:736474 6480464 Isotretinoin results in decreased expression of G6PD mRNA CTD PMID:20436886 isotretinoin multiple interactions ISO RGD:10608 6480464 Isotretinoin inhibits the reaction [Benzoyl Peroxide results in decreased activity of G6PD protein] CTD PMID:15225900 isotretinoin increases expression ISO RGD:736474 6480464 Isotretinoin results in increased expression of G6PD mRNA CTD PMID:15982314 ketoconazole increases expression ISO RGD:736474 6480464 Ketoconazole results in increased expression of G6PD mRNA CTD PMID:25399406 L-ascorbic acid multiple interactions ISO RGD:10608 6480464 Ascorbic Acid inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein] CTD PMID:18548748 L-glutamine multiple interactions EXP 6480464 Glutamine inhibits the reaction [Fructose results in decreased expression of G6PD protein] CTD PMID:31233715 lead diacetate decreases activity EXP 6480464 lead acetate results in decreased activity of G6PD protein CTD PMID:25228019 , PMID:30980912 lead diacetate multiple interactions EXP 6480464 [naringenin co-treated with lead acetate] results in decreased activity of G6PD protein CTD PMID:25228019 lead nitrate decreases activity EXP 6480464 lead nitrate results in decreased activity of G6PD protein CTD PMID:28557068 lovastatin multiple interactions ISO RGD:10608 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of G6PD mRNA CTD PMID:29852127 malathion multiple interactions EXP 6480464 [Malathion co-treated with Carbaryl] results in increased activity of G6PD protein, Plant Extracts inhibits the reaction [[Malathion co-treated with Carbaryl] results in increased activity of G6PD protein] CTD PMID:27214522 malathion increases activity EXP 6480464 Malathion results in increased activity of G6PD protein CTD PMID:27214522 melatonin increases activity EXP 6480464 Melatonin results in increased activity of G6PD protein CTD PMID:16224550 melatonin multiple interactions ISO RGD:10608 6480464 Melatonin inhibits the reaction [sodium arsenite results in decreased expression of G6PD protein] CTD PMID:29763682 melatonin multiple interactions ISO RGD:736474 6480464 [essential 303 forte co-treated with Silymarin co-treated with Melatonin analog] affects the activity of G6PD protein CTD PMID:25903262 mercury atom decreases activity ISO RGD:736474 6480464 Mercury results in decreased activity of G6PD protein CTD PMID:10798623 mercury dichloride increases activity EXP 6480464 Mercuric Chloride results in increased activity of G6PD protein CTD PMID:15977196 mercury(0) decreases activity ISO RGD:736474 6480464 Mercury results in decreased activity of G6PD protein CTD PMID:10798623 metformin increases expression EXP 6480464 Metformin results in increased expression of G6PD mRNA CTD PMID:31324951 methapyrilene multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Methapyrilene] results in increased expression of G6PD protein CTD PMID:28903497 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of G6PD mRNA CTD PMID:28903497 , PMID:30467583 methotrexate decreases activity EXP 6480464 Methotrexate results in decreased activity of G6PD protein CTD PMID:21213337 methotrexate multiple interactions EXP 6480464 Leucovorin inhibits the reaction [Methotrexate results in decreased activity of G6PD protein] CTD PMID:21213337 methoxychlor increases expression ISO RGD:10608 6480464 Methoxychlor results in increased expression of G6PDX mRNA CTD PMID:10433208 methyl salicylate increases expression ISO RGD:736474 6480464 methyl salicylate results in increased expression of G6PD mRNA CTD PMID:20566472 methylene blue increases activity ISO RGD:736474 6480464 Methylene Blue results in increased activity of G6PD protein CTD PMID:1901343 methylmercury chloride increases expression ISO RGD:736474 6480464 methylmercuric chloride results in increased expression of G6PD mRNA CTD PMID:28001369 metoprolol multiple interactions EXP 6480464 Metoprolol inhibits the reaction [Norepinephrine results in increased activity of G6PD protein] CTD PMID:1378361 monocrotophos affects activity EXP 6480464 Monocrotophos affects the activity of G6PD protein CTD PMID:24248738 monocrotophos multiple interactions EXP 6480464 [Monocrotophos co-treated with quinalphos] affects the activity of G6PD protein CTD PMID:24248738 monosodium L-glutamate multiple interactions ISO RGD:10608 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of G6PDX mRNA CTD PMID:19001666 myo-inositol hexakisphosphate multiple interactions EXP 6480464 [Phytic Acid co-treated with Inositol] inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] CTD PMID:28757134 myricetin multiple interactions EXP 6480464 myricetin inhibits the reaction [[Streptozocin co-treated with Cadmium] results in decreased activity of G6PD protein] CTD PMID:24923654 N,N'-diphenyl-1,4-phenylenediamine multiple interactions EXP 6480464 N, N'-diphenyl-4-phenylenediamine inhibits the reaction [Carbon Tetrachloride results in increased expression of G6PDX protein] CTD PMID:61145 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:736474 6480464 N more ... CTD PMID:12888634 , PMID:17018880 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of G6PD mRNA], Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of G6PD mRNA] CTD PMID:12717738 , PMID:15225644 N-acetyl-L-cysteine increases activity EXP 6480464 Acetylcysteine results in increased activity of G6PD protein CTD PMID:3099627 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of G6PD protein more ... CTD PMID:16188247 more ... N-nitrosodiethylamine increases expression ISO RGD:10608 6480464 Diethylnitrosamine results in increased expression of G6PDX mRNA CTD PMID:24535843 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of G6PDX mRNA CTD PMID:19638242 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of G6PDX protein CTD PMID:19716841 NADP zwitterion increases reduction ISO RGD:736474 6480464 G6PD protein results in increased reduction of NADP CTD PMID:5432368 NADP zwitterion increases expression EXP 6480464 NADP results in increased expression of G6PD protein CTD PMID:1922005 NADP(+) increases reduction ISO RGD:736474 6480464 G6PD protein results in increased reduction of NADP CTD PMID:5432368 NADP(+) increases expression EXP 6480464 NADP results in increased expression of G6PD protein CTD PMID:1922005 naringin multiple interactions EXP 6480464 naringin inhibits the reaction [nickel sulfate results in decreased activity of G6PD protein] CTD PMID:20950607 naringin multiple interactions ISO RGD:10608 6480464 naringin affects the reaction [LEPR protein affects the activity of G6PD protein] CTD PMID:16427799 nickel dichloride increases expression ISO RGD:10608 6480464 nickel chloride results in increased expression of G6PDX mRNA CTD PMID:12426141 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of G6PD mRNA CTD PMID:22546817 nickel sulfate increases expression ISO RGD:736474 6480464 nickel sulfate results in increased expression of G6PD mRNA CTD PMID:20566472 nickel sulfate decreases activity EXP 6480464 nickel sulfate results in decreased activity of G6PD protein CTD PMID:20950607 nickel sulfate multiple interactions EXP 6480464 naringin inhibits the reaction [nickel sulfate results in decreased activity of G6PD protein] CTD PMID:20950607 nicotinamide multiple interactions EXP 6480464 [Streptozocin co-treated with Niacinamide] affects the activity of G6PD protein, resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] affects the activity of G6PD protein] CTD PMID:19059388 nicotine decreases activity EXP 6480464 Nicotine results in decreased activity of G6PD protein CTD PMID:20498001 nitroprusside multiple interactions ISO RGD:736474 6480464 Zinc Sulfate promotes the reaction [Nitroprusside results in increased expression of G6PD mRNA] CTD PMID:17018880 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of G6PD protein CTD PMID:19260726 norfenefrine multiple interactions EXP 6480464 Prazosin inhibits the reaction [norfenefrine results in increased activity of G6PD protein] CTD PMID:1378361 norfenefrine increases activity EXP 6480464 norfenefrine results in increased activity of G6PD protein CTD PMID:1378361 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of G6PD mRNA CTD PMID:27638505 paracetamol affects expression ISO RGD:10608 6480464 Acetaminophen affects the expression of G6PDX mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:10608 6480464 Acetaminophen results in increased expression of G6PDX mRNA CTD PMID:29246445 paracetamol multiple interactions ISO RGD:10608 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of G6PDX mRNA] CTD PMID:29246445 paracetamol increases expression ISO RGD:736474 6480464 Acetaminophen results in increased expression of G6PD mRNA, Acetaminophen results in increased expression of G6PD protein CTD PMID:22230336 , PMID:25399406 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of G6PDX mRNA, Acetaminophen affects the expression of G6PDX protein CTD PMID:15800402 , PMID:18246545 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of G6PDX mRNA CTD PMID:17202762 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of G6PDX mRNA CTD PMID:18246545 paraquat increases activity EXP 6480464 Paraquat results in increased activity of G6PDX protein CTD PMID:10699569 perfluorooctanoic acid decreases expression ISO RGD:10608 6480464 perfluorooctanoic acid results in decreased expression of G6PDX mRNA CTD PMID:30711707 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased activity of G6PD protein, Plant Extracts inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in decreased activity of G6PD protein] CTD PMID:16188247 phenylmercury acetate increases expression ISO RGD:736474 6480464 Phenylmercuric Acetate results in increased expression of G6PD mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736474 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of G6PD mRNA CTD PMID:27188386 phenytoin affects response to substance ISO RGD:10608 6480464 G6PDX protein affects the susceptibility to Phenytoin CTD PMID:10627286 phorbol 13-acetate 12-myristate decreases expression ISO RGD:10608 6480464 Tetradecanoylphorbol Acetate results in decreased expression of G6PD protein CTD PMID:23399806 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10608 6480464 geraniol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of G6PD protein] CTD PMID:23399806 piperonyl butoxide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of G6PD protein CTD PMID:28903497 pirinixic acid multiple interactions ISO RGD:10608 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of G6PDX mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of G6PDX mRNA CTD PMID:19162173 potassium bromate multiple interactions EXP 6480464 Taurine inhibits the reaction [potassium bromate results in decreased activity of G6PD protein] CTD PMID:25213677 potassium bromate decreases activity EXP 6480464 potassium bromate results in decreased activity of G6PD protein CTD PMID:25213677 potassium chromate multiple interactions ISO RGD:10608 6480464 [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of G6PDX mRNA] CTD PMID:14625279 potassium chromate decreases activity ISO RGD:736474 6480464 potassium chromate(VI) results in decreased activity of G6PD protein CTD PMID:7753043 potassium dichromate decreases activity ISO RGD:736474 6480464 Potassium Dichromate results in decreased activity of G6PD protein CTD PMID:21681464 , PMID:29665407 potassium dichromate multiple interactions ISO RGD:736474 6480464 protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of G6PD protein] CTD PMID:29665407 potassium dichromate decreases activity EXP 6480464 Potassium Dichromate results in decreased activity of G6PD protein CTD PMID:1512015 potassium dichromate multiple interactions ISO RGD:10608 6480464 [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of G6PDX mRNA] CTD PMID:14625279 prazosin multiple interactions EXP 6480464 Prazosin inhibits the reaction [Norepinephrine results in increased activity of G6PD protein], Prazosin inhibits the reaction [norfenefrine results in increased activity of G6PD protein] CTD PMID:1378361 primaquine affects response to substance ISO RGD:736474 6480464 G6PD protein affects the susceptibility to Primaquine CTD PMID:19616568 primaquine decreases response to substance ISO RGD:736474 6480464 G6PD protein results in decreased susceptibility to Primaquine CTD PMID:22330256 promethazine increases expression EXP 6480464 Promethazine results in increased expression of G6PD mRNA CTD PMID:28903497 propan-2-ol increases expression ISO RGD:736474 6480464 2-Propanol results in increased expression of G6PD mRNA CTD PMID:20566472 propetamphos multiple interactions EXP 6480464 [cypermethrin co-treated with propetamphos] results in decreased activity of G6PD protein CTD PMID:25926273 propetamphos decreases activity EXP 6480464 propetamphos results in decreased activity of G6PD protein CTD PMID:25926273 pyrroles increases activity ISO RGD:736474 6480464 Pyrroles results in increased activity of G6PD protein CTD PMID:1901343 quartz multiple interactions ISO RGD:10608 6480464 Glutathione inhibits the reaction [Quartz results in decreased activity of G6PDX protein] CTD PMID:18370412 quartz decreases activity ISO RGD:10608 6480464 Quartz results in decreased activity of G6PDX protein CTD PMID:18370412 quercetin multiple interactions EXP 6480464 Quercetin analog inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein], Quercetin inhibits the reaction [Cadmium results in decreased expression of G6PD protein] CTD PMID:19615871 , PMID:20371363 quercetin increases expression ISO RGD:736474 6480464 Quercetin results in increased expression of G6PD mRNA CTD PMID:21632981 quinalphos affects activity EXP 6480464 quinalphos affects the activity of G6PD protein CTD PMID:24248738 quinalphos multiple interactions EXP 6480464 [Monocrotophos co-treated with quinalphos] affects the activity of G6PD protein CTD PMID:24248738 quinolinic acid increases activity EXP 6480464 Quinolinic Acid results in increased activity of G6PD protein CTD PMID:30876764 rac-lactic acid increases expression ISO RGD:736474 6480464 Lactic Acid results in increased expression of G6PD mRNA CTD PMID:20566472 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of G6PD mRNA CTD PMID:18299717 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] affects the activity of G6PD protein] CTD PMID:19059388 resveratrol decreases activity EXP 6480464 resveratrol results in decreased activity of G6PD protein CTD PMID:24012391 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of G6PD mRNA CTD PMID:28374803 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression EXP 6480464 Buthionine Sulfoximine results in increased expression of G6PD mRNA CTD PMID:12717738 SB 431542 multiple interactions ISO RGD:736474 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of G6PD mRNA CTD PMID:27188386 serpentine asbestos decreases activity ISO RGD:736474 6480464 Asbestos, Serpentine results in decreased activity of G6PD protein CTD PMID:16039947 , PMID:18370412 serpentine asbestos multiple interactions EXP 6480464 [Kerosene co-treated with Asbestos, Serpentine] results in increased activity of G6PD protein, [Soot co-treated with Asbestos, Serpentine] results in increased activity of G6PD protein CTD PMID:9177657 silibinin multiple interactions EXP 6480464 Silybin inhibits the reaction [Arsenic results in decreased activity of G6PD protein] CTD PMID:22229868 silicon dioxide affects secretion ISO RGD:736474 6480464 Silicon Dioxide analog affects the secretion of G6PD protein CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:736474 6480464 Silicon Dioxide analog results in decreased expression of G6PD mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:10608 6480464 Silver results in increased expression of G6PDX mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:10608 6480464 Silver results in increased expression of G6PDX mRNA CTD PMID:27131904 silver(1+) nitrate decreases activity EXP 6480464 Silver Nitrate results in decreased activity of G6PD protein CTD PMID:28557068 sinapic acid decreases activity ISO RGD:736474 6480464 sinapinic acid results in decreased activity of G6PD protein CTD PMID:25130191 sodium arsenite increases expression ISO RGD:736474 6480464 sodium arsenite results in increased expression of G6PD mRNA, sodium arsenite results in increased expression of G6PD protein CTD PMID:24866292 more ... sodium arsenite decreases expression ISO RGD:10608 6480464 sodium arsenite results in decreased expression of G6PD protein CTD PMID:29763682 sodium arsenite decreases activity ISO RGD:736474 6480464 sodium arsenite results in decreased activity of G6PD protein CTD PMID:29732668 sodium arsenite multiple interactions ISO RGD:736474 6480464 protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] CTD PMID:29732668 sodium arsenite affects methylation ISO RGD:736474 6480464 sodium arsenite affects the methylation of G6PD gene CTD PMID:28589171 sodium arsenite multiple interactions EXP 6480464 Quercetin analog inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] CTD PMID:20371363 sodium arsenite decreases activity ISO RGD:10608 6480464 sodium arsenite results in decreased activity of G6PD protein CTD PMID:19635623 sodium arsenite increases expression ISO RGD:10608 6480464 sodium arsenite results in increased expression of G6PDX mRNA CTD PMID:20883709 sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of G6PD protein CTD PMID:10996542 sodium arsenite decreases activity EXP 6480464 sodium arsenite results in decreased activity of G6PD protein CTD PMID:20371363 sodium arsenite multiple interactions ISO RGD:10608 6480464 Melatonin inhibits the reaction [sodium arsenite results in decreased expression of G6PD protein] more ... CTD PMID:19635623 , PMID:29763682 sodium chlorate decreases activity EXP 6480464 sodium chlorate results in decreased activity of G6PD protein CTD PMID:28084674 sodium dodecyl sulfate increases expression ISO RGD:736474 6480464 Sodium Dodecyl Sulfate results in increased expression of G6PD mRNA CTD PMID:20566472 sodium fluoride multiple interactions ISO RGD:10608 6480464 sodium arsenite inhibits the reaction [Sodium Fluoride results in decreased activity of G6PD protein], Sodium Fluoride inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] CTD PMID:19635623 sodium fluoride decreases activity ISO RGD:10608 6480464 Sodium Fluoride results in decreased activity of G6PD protein CTD PMID:19635623 sodium nitrate decreases activity EXP 6480464 sodium nitrate results in decreased activity of G6PD protein CTD PMID:19922758 sodium nitrite decreases activity ISO RGD:736474 6480464 Sodium Nitrite results in decreased activity of G6PD protein CTD PMID:26231821 streptozocin multiple interactions EXP 6480464 4-hydroxyphenylethanol inhibits the reaction [Streptozocin results in decreased activity of G6PD protein] more ... CTD PMID:19059388 more ... streptozocin decreases activity EXP 6480464 Streptozocin results in decreased activity of G6PD protein CTD PMID:19133311 more ... sulforaphane increases expression ISO RGD:736474 6480464 sulforafan results in increased expression of G6PD mRNA CTD PMID:26833863 sunitinib increases expression ISO RGD:736474 6480464 Sunitinib results in increased expression of G6PD mRNA CTD PMID:31533062 T-2 Toxin affects expression EXP 6480464 T-2 Toxin affects the expression of G6PD protein CTD PMID:26141394 T-2 Toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of G6PD mRNA CTD PMID:26141394 tadalafil increases activity EXP 6480464 Tadalafil results in increased activity of G6PD protein CTD PMID:24911673 tamoxifen affects expression ISO RGD:736474 6480464 Tamoxifen affects the expression of G6PD mRNA CTD PMID:14699072 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of G6PDX mRNA CTD PMID:19224547 taurine multiple interactions ISO RGD:10608 6480464 Taurine inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein] CTD PMID:18414974 more ... taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [potassium bromate results in decreased activity of G6PD protein] CTD PMID:25213677 terbutaline increases activity EXP 6480464 Terbutaline results in increased activity of G6PD protein CTD PMID:1978808 tert-butyl hydroperoxide decreases activity ISO RGD:736474 6480464 tert-Butylhydroperoxide results in decreased activity of G6PD protein CTD PMID:12628296 tert-butyl hydroperoxide increases activity EXP 6480464 tert-Butylhydroperoxide results in increased activity of G6PD protein CTD PMID:16928893 tert-butyl hydroperoxide increases activity ISO RGD:10608 6480464 tert-Butylhydroperoxide results in increased activity of G6PD protein CTD PMID:15336504 tert-butyl hydroperoxide increases activity ISO RGD:736474 6480464 tert-Butylhydroperoxide results in increased activity of G6PD protein CTD PMID:15336504 testosterone multiple interactions ISO RGD:736474 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of G6PD mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:736474 6480464 Testosterone results in increased expression of G6PD mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of G6PD mRNA, Carbon Tetrachloride results in increased expression of G6PDX protein CTD PMID:31150632 , PMID:61145 tetrachloromethane increases expression ISO RGD:10608 6480464 Carbon Tetrachloride results in increased expression of G6PDX mRNA CTD PMID:15056808 , PMID:27339419 tetrachloromethane multiple interactions EXP 6480464 Aminoacetonitrile inhibits the reaction [Carbon Tetrachloride results in increased expression of G6PDX protein] more ... CTD PMID:31150632 , PMID:61145 thimerosal decreases expression ISO RGD:736474 6480464 Thimerosal results in decreased expression of G6PD mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of G6PD mRNA, Thioacetamide results in increased expression of G6PDX protein CTD PMID:23411599 more ... thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of G6PD protein, [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of G6PDX mRNA CTD PMID:28903497 , PMID:28943392 titanium dioxide multiple interactions ISO RGD:736474 6480464 [Vitallium analog binds to titanium dioxide] which results in increased expression of G6PD mRNA CTD PMID:23825117 trans-caffeic acid decreases activity ISO RGD:736474 6480464 caffeic acid results in decreased activity of G6PD protein CTD PMID:25130191 trans-isoeugenol increases expression ISO RGD:736474 6480464 isoeugenol results in increased expression of G6PD mRNA CTD PMID:20566472 trans-piceid decreases activity ISO RGD:736474 6480464 polydatin results in decreased activity of G6PD protein CTD PMID:25130191 trichloroethene increases expression ISO RGD:10608 6480464 Trichloroethylene results in increased expression of G6PDX mRNA CTD PMID:25549359 troglitazone increases expression ISO RGD:10608 6480464 troglitazone results in increased expression of G6PD mRNA CTD PMID:28973697 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of G6PD mRNA CTD PMID:24136188 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of G6PDX mRNA CTD PMID:19224547 valproic acid increases expression ISO RGD:736474 6480464 Valproic Acid results in increased expression of G6PD mRNA CTD PMID:25399406 , PMID:29154799 valproic acid increases methylation ISO RGD:736474 6480464 Valproic Acid results in increased methylation of G6PD gene CTD PMID:29154799 valproic acid affects expression ISO RGD:736474 6480464 Valproic Acid affects the expression of G6PD mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of G6PD mRNA CTD PMID:23034163 vitamin E multiple interactions ISO RGD:10608 6480464 Vitamin E inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] CTD PMID:19635623 vorinostat decreases expression ISO RGD:736474 6480464 vorinostat results in decreased expression of G6PD mRNA CTD PMID:27188386 zinc atom affects activity EXP 6480464 Zinc affects the activity of G6PD protein CTD PMID:17181878 zinc dichloride multiple interactions EXP 6480464 zinc chloride inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein] CTD PMID:18972399 zinc sulfate multiple interactions ISO RGD:736474 6480464 Zinc Sulfate promotes the reaction [Nitroprusside results in increased expression of G6PD mRNA] CTD PMID:17018880 zinc sulfate increases expression ISO RGD:736474 6480464 Zinc Sulfate results in increased expression of G6PD mRNA CTD PMID:17018880 zinc(0) affects activity EXP 6480464 Zinc affects the activity of G6PD protein CTD PMID:17181878
Gene-Chemical Interaction Annotations
